Cardiovascular

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide. At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heart beats (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure (hypertension) or heart attack (myocardial infarction).


Myocardial infarction (heart attack) is a leading cause of death worldwide and is responsible for approximately 42 percent of all deaths from cardiovascular disease. Heart attacks occur when the blood supply to an area of the heart is blocked by a blood clot or atherosclerosis (fatty deposits or plaques lining vessel walls), causing heart tissue to die.  Rapid diagnosis and treatment to restore blood flow through the affected vessel are vital to save as much of the heart tissue as possible.

General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers